Cited by 604SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

The DOI matches its Crossref record; 11 of the 12 references it cites were found in a registry or an index.

Genetic Variants of SARS-CoV-2—What Do They Mean?

Open access

Lauring, Adam S., Hodcroft, Emma B.·2021·JAMA

DOI 10.1001/jama.2020.27124

Open this paper in CoChat — free account Open PDF

Abstract

This Viewpoint discusses emerging genetic variants of SARS-CoV-2, including new “UK” and “mink” variants and the significance of the new variants to coronavirus transmissibility, spread, virulence, and efforts to vaccinate the population against COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2020.27124

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Spike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans
Munnink, B. B. O., Sikkema, R. S., Nieuwenhuijse, D. F., Molenaar, R. J., Münger, E., Molenkamp, R., van der Spek, A. N., Tolsma, P., Rietveld, A., Brouwer, M., et al. (2020) · Science · doi:10.1126/science.abe5901 · Cited by 1,116
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.012 · Cited by 324
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityPreprint
Volz, E., Hill, V., McCrone, J., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20166082 · Cited by 313
We shouldn’t worry when a virus mutates during disease outbreaks
Grubaugh, N. D., Petrone, M. E., & Holmes, E. C. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0690-4 · Cited by 168

Show all 12 references

Sorted by citations

Items 301–400 of 585

Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia
Massi, M. N., Abidin, R. S., Farouk, A., Halik, H., Soraya, G. V., Hidayah, N., Sjahril, R., Handayani, I., Hakim, M. S., Gazali, F. M., et al. (2022) · PeerJ · doi:10.7717/peerj.13522 · Cited by 7
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern
Rudi, E., Aispuro, P. M., Zurita, E., Ledesma, M. M. G. L., Bottero, D., Malito, J. P., Gabrielli, M., Gaillard, M. E., Stuible, M., Durocher, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020159 · Cited by 7
SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA
Ramasamy, S., Gontu, A., Neerukonda, S. N., Ruggiero, D., Morrow, B. L., Gupta, S., Amirthalingam, S., Hardham, J. M., Lizer, J. T., Yon, M., et al. (2023) · Viruses · doi:10.3390/v15071493 · Cited by 7
An expanded RT-PCR melting temperature coding assay to rapidly identify all known SARS-CoV-2 variants and sub-variants of concern
Banada, P. P., Green, R., Streck, D. L., Kurvathi, R., Reiss, R., Banik, S., Daivaa, N., Montalvan, I., Jones, R., Marras, S. A. E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-48647-8 · Cited by 7
Recommended distances for physical distancing during COVID-19 pandemics reveal cultural connections between countries
Chai, D., Mossadeq, L. E., Michel Raymond, A., & Courtier‐Orgogozo, V. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289998 · Cited by 7
Molecular epidemiology of SARS-CoV-2 in Northern South Africa: wastewater surveillance from January 2021 to May 2022
Tambe, L. A. M., Mathobo, P., Matume, N. D., Munzhedzi, M., Edokpayi, J. N., Viraragavan, A., Glanzmann, B., Tebit, D. M., Mavhandu-Ramarumo, L. G., Street, R. A., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1309869 · Cited by 7
Up, up, down, down: the structural biology of the SARS-CoV-2 spike protein and how it cheats the immune system
Stäb, S., Pearce, N. M., Tronrud, D. E., Ginn, H. M., Fadda, E., Santoni, G., & Thorn, A. (2024) · Crystallography Reviews · doi:10.1080/0889311x.2024.2363756 · Cited by 7
Dynamics of an SVEIR transmission model with protection awareness and two strains
Chen, K., Wei, F., Zhang, X., Jin, H., Zhou, R., Zuo, Y., & Fan, K. (2024) · Infectious Disease Modelling · doi:10.1016/j.idm.2024.10.001 · Cited by 7
The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic
Izadmehr, S., Lundon, D., Mohamed, N., Katims, A., Patel, V. G., Eilender, B. M., Mehrazin, R., Badani, K. K., Sfakianos, J. P., Tsao, C., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.734963 · Cited by 7
A single early introduction governed viral diversity in the second wave of SARS-CoV-2 epidemic in Hungary
Ari, E. E., Vásárhelyi, B. M., Kemenesi, G., Tóth, G. E., Zana, B., Somogyi, B. A., Lanszki, Z., Röst, G., Jakab, F., Papp, B., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac069 · Cited by 7
The Impact of Demographic, Clinical Characteristics and the Various COVID-19 Variant Types on All-Cause Mortality: A Case-Series Retrospective Study
Khamis, F., Awaidy, S. A., Ba'Omar, M., Osman, W., Chhetri, S., Ambusaid, Z., Fahdi, Z. A., Al-Lawati, J., Sulaimi, K. A., Bulushi, S. A., et al. (2022) · Diseases · doi:10.3390/diseases10040100 · Cited by 4
Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages
Ravi, V., Shamim, U., Khan, M. A., Swaminathan, A., Mishra, P., Rajender, S., Bharali, P., Chauhan, N. S., & Pandey, R. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1294699 · Cited by 7
The Role of Animal Research in Pandemic Responses
Brockhurst, J., & Villano, J. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000062 · Cited by 7
Superspreading events of SARS-CoV-2 in Paris: A retrospective analysis of data from the first wave of COVID-19 in 2020
Deslandes, A., Calba, C., Mahdjoub, S., Zhu-Soubise, A., Mahdjoub, S., & Ardoin, A. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.001 · Cited by 7
Developmental Aspects of SARS-CoV-2, Potential Role of Exosomes and Their Impact on the Human Transcriptome
Dogra, N., Ledesma‐Feliciano, C., & Sen, R. (2021) · Journal of Developmental Biology · doi:10.3390/jdb9040054 · Cited by 7
Community Knowledge of and Attitudes towards COVID-19 Prevention Techniques in Saudi Arabia: A Cross-Sectional Study
AbuAlhommos, A. K., Alhadab, F. E., Almajhad, M. M., Almutawaa, R., & Alabdulkareem, S. T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312783 · Cited by 7
Fundamentals of genomic epidemiology, lessons learned from the coronavirus disease 2019 (COVID-19) pandemic, and new directions
Machado, D. J., White, R. A., III, Kofsky, J., & Janies, D. A. (2021) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2021.222 · Cited by 8
Molecular Insights of SARS-CoV-2 Antivirals Administration: A Balance between Safety Profiles and Impact on Cardiovascular Phenotypes
Nappi, F., Iervolino, A., & Singh, S. (2022) · Biomedicines · doi:10.3390/biomedicines10020437 · Cited by 8
Explainability of the COVID-19 epidemiological model with nonnegative tensor factorization
Balasubramaniam, T., Warne, D. J., Nayak, R., & Mengersen, K. L. (2022) · International Journal of Data Science and Analytics · doi:10.1007/s41060-022-00324-1 · Cited by 7
Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination
Bonura, F., Genovese, D., Amodio, E., Calamusa, G., Sanfilippo, G. L., Cacioppo, F., Giammanco, A., Grazia, S. D., & Ferraro, D. (2022) · Vaccines · doi:10.3390/vaccines10060874 · Cited by 8
Should RECOVERY have used response adaptive randomisation? Evidence from a simulation study
Sirkis, T., Jones, B., & Bowden, J. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01691-w · Cited by 7
The SARS-CoV-2 Variants and their Impacts
Shukri, A. M. A., Wang, S. M., Chia, S. L., & Nawi, S. F. A. M. (2022) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.16.3.45 · Cited by 8
Machine learning risk estimation and prediction of death in continuing care facilities using administrative data
Shahidi, F., Rennert‐May, E., D’Souza, A. G., Crocker, A., Faris, P., & Leal, J. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-43943-9 · Cited by 7
Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account
Umair, M., Salman, M., Rehman, Z., Badar, N., Ali, Q., Ahad, A., & Ikram, A. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.683378 · Cited by 7
Evaluation of Hybrid Unsupervised and Supervised Machine Learning Approach to Detect Self-Reporting of COVID-19 Symptoms on Twitter
Cai, M., Li, J., Nali, M. C., & Mackey, T. K. (2021) · IEEE International Conference on Communications workshops · doi:10.1109/iccworkshops50388.2021.9473830 · Cited by 7
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2
Ruiz-Rodríguez, P., Francés-Gómez, C., Chiner‐Oms, Á., López, M. G., Jiménez-Serrano, S., Cancino‐Muñoz, I., Ruiz-Hueso, P., Torres‐Puente, M., Bracho, M. A., D’Auria, G., et al. (2021) · mBio · doi:10.1128/mbio.02315-21 · Cited by 8
Stronger together: a new pandemic agenda for South Asia
Bandara, S., Bhaumik, S., Sriram, V., Saha, S., Zia, N., Hasan, M. Z., Malavige, G. N., & Rasali, D. P. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006776 · Cited by 7
AlphaFold2 Reveals Structural Patterns of Seasonal Haplotype Diversification in SARS-CoV-2 Nucleocapsid Protein Variants
Ali, M. A., & Caetano-Anollés, G. (2024) · Viruses · doi:10.3390/v16091358 · Cited by 6
“…comprises five distinct regions, two of which are structured and are known as the N-Terminal Domain (NTD) (residues 44– 174 ) and the C-Terminal C-Terminal Domain ( CTD ) ( residues Variants of Concern (VOCs) have been replacing each other since the beginning of the COVID-19 pandemic [28].”
Background
Insight into genomic organization of pathogenic coronaviruses, SARS-CoV-2: Implication for emergence of new variants, laboratory diagnosis and treatment options
Bedada, F. B., Gorfu, G., Teng, S., & Neita, M. E. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.917201 · Cited by 6
Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study
Gobena, D., Gudina, E. K., Yilma, D., Girma, T., Gebre, G., Gelanew, T. I., Abdissa, A., Mulleta, D., Sarbessa, T., Asefa, H., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280801 · Cited by 6
Development of a universal real-time RT-PCR assay for detection of pan-SARS-coronaviruses with an RNA-based internal control
Yu, B., Xu, C., Huang, S., Ni, J., Zhou, J., Zhang, Y., Wu, M., Zhang, J., & Fang, L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1181097 · Cited by 6
Development and application of an RT‒PCR assay for the identification of the delta and omicron variants of SARS-COV-2
Shipulin, G. A., Savochkina, Y. A., Shuryaeva, A. K., Glushchenko, E. E., Luparev, A. R., Polyakova, V. A., Danilov, D., Евгеньевна, Д. Е., Vinogradov, K. S., Stetsenko, I. F., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16917 · Cited by 6
Impact of E484Q and L452R Mutations on Structure and Binding Behavior of SARS-CoV-2 B.1.617.1 Using Deep Learning AlphaFold2, Molecular Docking and Dynamics Simulation
Jiao, Y., Xing, Y., & Sun, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411564 · Cited by 6
Focused Review: Insight and Updates on COVID-19 from Progress in Microbes and Molecular Biology
Thye, A. Y.-K., & Law, J. W. (2023) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000333 · Cited by 6
Wastewater sequencing as a powerful tool to reveal SARS-CoV-2 variant introduction and spread in French Guiana, South America
Combe, M., Chérif, E., Deremarque, T., Rivera‐Ingraham, G. A., Seck-Thiam, F., Justy, F., Doudou, J.-C., Carod, J.-F., Carage, T., Procureur, A., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171645 · Cited by 6
Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody
Galili, U. (2021) · Medical Research Archives · doi:10.18103/mra.v9i7.2481 · Cited by 6
COVID-19 variants as moving targets and how to stop them by glycoengineered whole-virus vaccines
Galili, U. (2021) · Virulence · doi:10.1080/21505594.2021.1939924 · Cited by 6
Reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay as a rapid molecular diagnostic tool for COVID-19 in healthcare workers
Barboza, V. D. S., Domingues, W. B., de Souza, T. T., Collares, T. V., Seixas, F. K., Pacheco, B. S., Sousa, F. S. S., Oliveira, T. L., Lima, M. D. O., de Pereira, C. M. P., et al. (2023) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2023.100134 · Cited by 7
Modeling SARS coronavirus-2 omicron variant dynamic via novel fractional derivatives with immunization and memory trace effects
Liu, T., Yin, X., Liu, Q., & Hounye, A. H. (2023) · Alexandria Engineering Journal · doi:10.1016/j.aej.2023.11.068 · Cited by 6
Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021–January 2022
Gerashchenko, G. V., Hryshchenko, N. V., Melnichuk, N., Marchyshak, T., Chernushyn, S. Y., Demchyshina, I. V., Chernenko, L. M., Kuzin, I., Tkachuk, Z. Y., Kashuba, V. I., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25618 · Cited by 7
Personalized Therapy: Can it Tame the COVID-19 Monster?
Arish, M., & Naz, F. (2021) · Personalized Medicine · doi:10.2217/pme-2021-0077 · Cited by 6
Development and Validation of Two RT-qPCR Diagnostic Assays for Detecting Severe Acute Respiratory Syndrome Coronavirus 2 Genomic Targets across Two Specimen Types
Miller, E. W., Lamberson, C. M., Akabari, R. R., Riddell, S. W., Middleton, F. A., Nasr, M. R., Smith, S. C., & Sperber, S. M. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.12.010 · Cited by 6
Sequential development of several RT‐qPCR tests using LNA nucleotides and dual probe technology to differentiate SARS‐CoV‐2 from influenza A and B
Radvánszka, M., Paul, E. D., Hajdu, R., Boršová, K., Kováčová, V., Putaj, P., Bírová, S., Čirková, I., Čarnecký, M., Buranovská, K., et al. (2022) · Microbial Biotechnology · doi:10.1111/1751-7915.14031 · Cited by 6
Visualized Genotyping from “Sample to Results” Within 25 Minutes by Coupling Recombinase Polymerase Amplification (RPA) With Allele-Specific Invasive Reaction Assisted Gold Nanoparticle Probes Assembling
Zhang, L., Ma, X., Liu, D., Shan, J., Chu, Y., Zhang, J., Qi, X., Huang, X., Zou, B., & Zhou, G. (2022) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2022.3258 · Cited by 6
Mutations of the SARS-CoV-2 Spike Glycoprotein Detected in Cats and Their Effect on Its Structure and Function
Hamdy, M. E., El‐Deeb, A. H., Hagag, N. M., Shahein, M. A., Alaidi, O., & Hussein, H. A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.875123 · Cited by 6
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Fang, Z., Peng, L., Lucas, C. G. D. O., Lin, Q., Zhou, L., Yang, L., Feng, Y., Ren, P., Renauer, P. A., Monteiro, V. S., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00435-w · Cited by 6
COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation
Yu, J., Azzam, E. I., Jadhav, A. B., & Wang, Y. (2021) · Cells · doi:10.3390/cells10092212 · Cited by 6
The Emergence of SARS-CoV-2 Variants With a Lower Antibody Response: A Genomic and Clinical Perspective
Biswas, S., Mahmud, S., Mita, M. A., Afrose, S., Hasan, M. R., Paul, G. K., Shimu, M. S. S., Uddin, M. S., Zaman, S., Park, M. N., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.825245 · Cited by 6
Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India
Singh, U. B., Deb, S., Rani, L., Gupta, R., Verma, S., Kumari, L., Bhardwaj, D., Bala, K., Ahmed, J., Gourav, S., et al. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2222832 · Cited by 6
Introductions and evolutions of SARS-CoV-2 strains in JapanPreprint
Tokumasu, R., Weeraratne, D., Snowdon, J. L., Parida, L., Kudo, M., & Koyama, T. (2021) · medRxiv · doi:10.1101/2021.02.26.21252555 · Cited by 6
Multi-site Evaluation of SARS-CoV-2 Spike Mutation Detection Using a Multiplex Real-time RT-PCR AssayPreprint
Bier, C., Edelmann, A., Theil, K., Schwarzer, R., Deichner, M., Gessner, A., Hiergeist, A., Rentschler, U., Gohl, P., Kuchta, A. L., et al. (2021) · medRxiv · doi:10.1101/2021.05.05.21254713 · Cited by 6
Diversidad genómica en SARS-CoV-2: Mutaciones y variantes
Aguilar–Gamboa, F. R., Suclupe-Campos, D. O., Vega-Fernández, J. A., & Silva-Díaz, H. (2021) · Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo · doi:10.35434/rcmhnaaa.2021.144.1465 · Cited by 5
A Simplified Sanger Sequencing Method for Detection of Relevant SARS-CoV-2 Variants
Deminco, F., Vaz, S. N., de Santana, D. S., Pedroso, C., Tadeu, J., Stöcker, A., Vieira, S. M., Netto, E. M., & Brites, C. R. (2022) · Diagnostics · doi:10.3390/diagnostics12112609 · Cited by 5
The functional views on response of host rabbit post coronavirus vaccination via ACE2 PET.
Xiao, L., Li, J., Zhou, P., Li, D., Wang, M., Tong, Q., Chen, J., Zuo, C., Zhang, L., & Li, R. (2023) · PubMed Central · Cited by 5
Mutation prediction and phylogenetic analysis of SARS-CoV2 protein sequences using LSTM based encoder-decoder model
Sah, S., Surendiran, B., Dhanalakshmi, R., & Mohanty, S. N. (2023) · Arab Journal of Basic and Applied Sciences · doi:10.1080/25765299.2023.2188677 · Cited by 5
Investigating and Analyzing Self-Reporting of Long COVID on Twitter: Findings from Sentiment Analysis
Thakur, N. (2023) · Applied System Innovation · doi:10.3390/asi6050092 · Cited by 7
Substitution spectra of SARS-CoV-2 genome from Pakistan reveals insights into the evolution of variants across the pandemic
Ashraf, J., Bukhari, A. R., Kanji, A., Iqbal, T., Yameen, M., Nisar, M. I., Khan, W., & Hasan, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-48272-5 · Cited by 5
What Are the Clinical Implications of the SARS-CoV-2 Variants
Rauseo, A. M., & O’Halloran, J. A. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.02.009 · Cited by 5
Role of Primary Care and Challenges for Public–Private Cooperation during the Coronavirus Disease 2019 Pandemic: An Expert Delphi Study in South Korea
Shin, W.-Y., Kim, C., Lee, S. Y., Lee, W. J., & Kim, J. (2021) · Yonsei Medical Journal · doi:10.3349/ymj.2021.62.7.660 · Cited by 5
Epidemiokinetic Tools to Monitor Lockdown Efficacy and Estimate the Duration Adequate to Control SARS-CoV-2 Spread
Mégarbane, B., Bourasset, F., & Scherrmann, J. (2021) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-021-00007-3 · Cited by 5
SARS-CoV-2 Variant Determination Through SNP Assays in Samples From Industry Workers From Rio de Janeiro, Brazil
Henriques‐Santos, B. M., Farjun, B., Corrêa, I. A., Figueiredo, J. D. B., Fidalgo-Neto, A. A., & Kuriyama, S. N. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.757783 · Cited by 5
Structure/Function Analysis of Truncated Amino-Terminal ACE2 Peptide Analogs That Bind to SARS-CoV-2 Spike Glycoprotein
Mackin, R. T., Edwards, J. V., Atuk, E. B., Beltrami, N., Condon, B., Jayawickramarajah, J., & French, A. D. (2022) · Molecules · doi:10.3390/molecules27072070 · Cited by 5
Brief dispersion of a putative B.1.1.28-derived SARS-CoV-2 lineage harboring additional N234P and E471Q spike protein mutations in individuals crossing the Argentina-Brazil border
da Silva, M. S., Gularte, J. S., Demoliner, M., Hansen, A. W., Heldt, F. H., Filippi, M., Luckmann, C. B., Pereira, V. M. D. A. G., Vaucher, R. D. A., Barboza, V. D. S., et al. (2022) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2022.102390 · Cited by 5
Cellular immunity in patients with COVID-19: molecular biology, pathophysiology, and clinical implications
Sсherbak, S. G., Vologzhanin, D. A., Голота, А. С., Kamilova, Т. A., & Макаренко, С. В. (2022) · Journal of clinical practice · doi:10.17816/clinpract106239 · Cited by 5
Euphorbia neriifolia Leaf Juice on Mild and Moderate COVID-19 Patients: Implications in OMICRON Era
Mahtab, M. A., Akbar, S. M. F., Pramanik, M. E. A., Miah, M. M. Z., Ahmed, I., Hossain, A. M., Ali, M., Haque, M. J., Islam, A. M., Jahan, R. A., et al. (2022) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1367 · Cited by 5
Is the Increased Transmissibility of SARS-CoV-2 Variants Driven by within or Outside-Host Processes?
Arav, Y., Fattal, E., & Klausner, Z. (2022) · Mathematics · doi:10.3390/math10193422 · Cited by 5
Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin
Hassan, S. S., Kodakandla, V., Redwan, E. M. M. M., Lundstrom, K. H., Choudhury, P. P., Serrano‐Aroca, Á., Azad, G. K., Aljabali, A. A. A., Palù, G., El‐Aziz, T. M. A., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.184 · Cited by 5
Involvement of KL-6 Biomarker in Interstitial Lung Disease Induced by SARS-CoV-2 Infection: A Systematic Review
Crișan-Dabija, R. A., Covic, A. C., Brinza, C., Popa, I. V., & Burlacu, A. (2021) · Applied Sciences · doi:10.3390/app11083482 · Cited by 5
Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations?
Kanakan, A., Mehta, P., Devi, P., Saifi, S., Swaminathan, A., Maurya, R., Chattopadhyay, P., Tarai, B., Das, P., Jha, V., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.763169 · Cited by 6
Battle against the pandemic: Emergence of SARS-CoV2 variants and global challenge
Kumar, S., Sharma, V., Sarkar, S., & Ludhiadch, A. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102173 · Cited by 5
High-frequency screening combined with diagnostic testing for control of SARS-CoV-2 in high-density settings: an economic evaluation of resources allocation for public health benefitPreprint
Rogers, W., Ruiz‐Aravena, M., Hansen, D., Madden, W. G., Kessler, M. K., Fields, M. W., Ferrari, M. J., Chang, C. B., Morrow, J. B., Hoegh, A. B., et al. (2021) · medRxiv · doi:10.1101/2021.03.04.21252949 · Cited by 5
SARS-CoV-2 mutational variants may represent a new challenge to society, but not to the virucidal armamentarium
Ijaz, M. K., Nims, R. W., & McKinney, J. (2021) · Journal of Hospital Infection · doi:10.1016/j.jhin.2021.03.013 · Cited by 5
COVID-19: Measles and Antibiotic Resistance Are a Matter of Concern
Guardo, G. D. (2021) · Pathogens · doi:10.3390/pathogens10040449 · Cited by 5
A colorimetric reverse-transcription loop-mediated isothermal amplification method targeting the L452R mutation to detect the Delta variant of SARS-CoV-2
Thippornchai, N., Pengpanich, S., Jaroenram, W., Kosoltanapiwat, N., Sukphopetch, P., Kiatpathomchai, W., & Leaungwutiwong, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-72417-9 · Cited by 4
Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19
Tokhanbigli, S., Ghaleh, S. S., Rahimian, K., Mahmanzar, M., Bayat, S., Ahangarzadeh, S., Moradi, B., Mahmanzar, R., Wang, Y., Oliver, B. G. G., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1435873 · Cited by 4
Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species
Fernández‐Bastit, L., Marfil, S., Pradenas, E., Blanco, J., Vergara‐Alert, J., & Segalés, J. (2025) · Viruses · doi:10.3390/v17050716 · Cited by 4
SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
Syahniar, R., & Kharisma, D. S. (2022) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2022.11.2.173 · Cited by 4
Multidimensional futuristic approaches to address the pandemics beyond COVID-19
Kotwal, S. B., Orekondey, N., Saradadevi, G. P., Priyadarshini, N., Puppala, N. V., Bhushan, M., Motamarry, S., Kumar, R., Mohannath, G., & Dey, R. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17148 · Cited by 4
Detection of SARS-CoV-2 infection in asymptomatic populations using the DiaSorin molecular Simplexa and Roche Cobas EUA assays
Antonara, S., Ozbolt, P., Landon, L., Fatica, L., Pleasant, T., Swickard, J., Drury, A., Wongchaowart, N. T., & Cradic, K. W. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115513 · Cited by 4
Genomic surveillance: Circulating lineages and genomic variation of SARS-CoV-2 in early pandemic in Ceará state, Northeast Brazil
Oliveira, F. A. D. S., de Holanda, M. V., Lima, L. B., Dantas, M. B., Duarte, I. O., de Castro, L. G. Z., de Oliveira, L. L. B., Paier, C. R. K., Moreira-Nunes, C. A., Lima, N. C. B., et al. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198908 · Cited by 4
Precision Medicine in Infectious Disease
Alvarez, M. J. R., Hasanzad, M., Meybodi, H. R. A., & Sarhangi, N. (2022) · Springer eBooks · doi:10.1007/978-981-19-5082-7_13 · Cited by 4
Characterization and phylogenetic analysis of Iranian SARS‐CoV‐2 genomes: A phylogenomic study
Aliabadi, N., Jamalidoust, M., Pouladfar, G., Marandi, N. H., & Ziyaeyan, M. (2023) · Health Science Reports · doi:10.1002/hsr2.1052 · Cited by 4
Predictors of death among severe COVID-19 patients admitted in Hawassa City, Sidama, Southern Ethiopia: Unmatched case-control study
Misganaw, S., Eshetu, B., Adane, A., & Solomon, T. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282478 · Cited by 4
How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
Haller, M. J., Jacobsen, L. M., Posgai, A. L., & Schatz, D. (2021) · Diabetes · doi:10.2337/dbi20-0045 · Cited by 4
La incógnita del coronavirus – Variantes y vacunas - La gestante y su niño
Romero, J. P. (2021) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v67i2311 · Cited by 5
Track the dynamical features for mutant variants of COVID-19 in the UK
Chen, R.-M. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021232 · Cited by 4
New SARS-CoV-2 Variant from Jordan
Alanagreh, L., Ababneh, M. M. K., Al-Shudifat, A.-E., Ajlouny, M., Abu-Shaikh, H., Alzoughool, F., Al‐Zghoul, M. B., Atoum, M. F. M., & Mahafzeh, A. (2021) · Microbiology Resource Announcements · doi:10.1128/mra.00532-21 · Cited by 4
Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study
Fischer, T., Baz, Y. E., Scanferla, G., Graf, N., Waldeck, F., Kleger, G., Frauenfelder, T., Bremerich, J., Kobbe, S. S., Pagani, J., et al. (2022) · European Journal of Radiology Open · doi:10.1016/j.ejro.2022.100431 · Cited by 4
Pattern of molecular mimicry between spike protein of SARS CoV2 and human thrombopoietin in beta, delta and omicron variants: a basic pathophysiological process of COVID-19 related thrombocytopenia.
Mungmunpuntipantip, R., & Wiwanitkit, V. (2022) · PubMed Central · Cited by 4
Mild reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant: First case report from Indonesia
Isnaini, N., Mardian, Y., Lokida, D., Budiono, F., Butar-butar, D. P., Arlinda, D., Salim, G., Kosasih, H., Wulan, W. N., Perodin, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.906469 · Cited by 4
Agile design and development of a high throughput cobas SARS-CoV-2 RT-PCR diagnostic test
Manohar, C. F., Sun, J., Schlag, P., Santini, C., Fontecha, M., Lötscher, P., Bier, C., Goepfert, K., Duncan, D., Spier, G., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10591 · Cited by 4
A machine learning COVID-19 mass screening based on symptoms and a simple olfactory test
Azeli, Y., Fernández, A., Capriles, F., Rojewski, W., Lopez-Madrid, V., Sabaté-Lissner, D., Serrano, R. M., Rey‐Reñones, C., Civit, M., Casellas, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19817-x · Cited by 4
How anxiety attributed to COVID-19, disease knowledge, and intention to vaccinate against SARS-CoV-2 viral infection prevail in general public of Saudi Arabia?
Islam, M. A., Alshayban, D., Naqvi, A. A., Maqsood, M. B., Ishaqui, A. A., Kashif, M., Ali, M., & Haseeb, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1078023 · Cited by 4
On forecasting of COVID-19 transmission in Saudi Arabia and Egypt using reservoir computing model
Elsadany, A. A., Aldurayhim, A., & Elsonbaty, A. (2023) · Alexandria Engineering Journal · doi:10.1016/j.aej.2023.02.028 · Cited by 4
Estimating the super-spreading rate at workplaces using bluetooth technologyPreprint
Vázquez, A., Staebler, M., Khanin, A., Lichte, D., & Brucherseifer, E. (2021) · medRxiv · doi:10.1101/2021.03.04.21252550 · Cited by 4
Rapid, widespread, and preferential increase of SARS-CoV-2 B.1.1.7 variant in Houston, TX, revealed by 8,857 genome sequencesPreprint
Musser, J. M., Olsen, R. J., Christensen, P. A., Long, S. W., Subedi, S., Davis, J. J., & Gollihar, J. (2021) · medRxiv · doi:10.1101/2021.03.16.21253753 · Cited by 4
ddPCR Reveals SARS-CoV-2 Variants in Florida WastewaterPreprint
Gering, E., Colbert, J., Schmedes, S. E., Duncan, G., Lopez, J. V., Motes, J., Weiss, J., Azarian, T., Tekin, O., & Blanton, J. L. (2021) · medRxiv · doi:10.1101/2021.04.08.21255119 · Cited by 4
Development and validation of blood-based prognostic biomarkers for severity of COVID disease outcome using EpiSwitch 3D genomic regulatory immuno-genetic profilingPreprint
Hunter, E., Koutsothanasi, C., Wilson, A. J., Santos, F. C., Salter, M., Westra, J. W., Powell, R., Dring, A. M., Brajer, P., Egan, B., et al. (2021) · medRxiv · doi:10.1101/2021.06.21.21259145 · Cited by 4
Covid-19 genomic analysis reveals clusters of emerging sublineages within the delta variantPreprint
Rono, E. K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.08.463334 · Cited by 5
S-gene Dropout and False-negative Reverse Transcriptase-polymerase Chain Reaction Tests
Balaji, S. (2021) · Annals of Maxillofacial Surgery · doi:10.4103/ams.ams_2_22 · Cited by 4

Authors: Lauring, A. S., & Hodcroft, E. B.
Affiliations: University of Michigan (US)
University of Bern (CH)
Corresponding author: Lauring, Adam S.
ORCID: Lauring, Adam S.
Hodcroft, Emma B.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2021-02-09
Volume: 325
Issue: 6
Pages: 529
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2020.27124
OpenAlex: W3119231619
Cited by: 604
References: 12
Citations by year: 2026: 9 · 2025: 20 · 2024: 39 · 2023: 72 · 2022: 197 · 2021: 264
FWCI: 45.16
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
Locations: JAMA (publishedVersion, cc-by)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords: SARS-CoV-2, genetic variants, UK variant, COVID-19 pandemic, transmissibility, virulence, COVID-19 vaccination, viral evolution
MeSH terms: COVID-19, SARS-CoV-2, COVID-19 Vaccines, Animals, Humans, Mink, Mutation, Phylogeny, Genetic Variation, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genetic Variants of SARS-CoV-2—What Do They Mean?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks